Prelude Therapeutics Inc (PRLD)

Dec 10, 2025

Prelude Therapeutics divulges new JAK2 inhibitors - BioWorld MedTech

Dec 10, 2025

Dec 10, 2025

It makes sense and dollars to buy Prelude Therapeutics Inc (PRLD) stock - setenews.com

Dec 10, 2025

Dec 08, 2025

Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens - Investing.com Canada

Dec 08, 2025

Dec 07, 2025

Prelude Therapeutics (PRLD) Reveals Promising Preclinical Data a - GuruFocus

Dec 07, 2025

Dec 06, 2025

Prelude Therapeutics Unveils Promising Preclinical Data for JAK2V617F-selective JH2 Inhibitor and mCALR-targeted Degrader Antibody Conjugate at ASH 2025 - Quiver Quantitative

Dec 06, 2025

Dec 06, 2025

Prelude Therapeutics (Nasdaq: PRLD) details MPN pipeline at 2025 ASH, eyes 2026 IND - Stock Titan

Dec 06, 2025

Dec 04, 2025

What insider trading reveals about Prelude Therapeutics Incorporated stockShort Setup & Daily Volume Surge Trade Alerts - Newser

Dec 04, 2025

Nov 28, 2025

VIX Spike: How Prelude Therapeutics Incorporated stock compares to industry benchmarksJuly 2025 Decliners & Growth Focused Stock Pick Reports - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

Growth Report: What dividend safety score for Prelude Therapeutics Incorporated stockJuly 2025 Big Picture & Daily Volume Surge Signals - moha.gov.vn

Nov 27, 2025

Nov 26, 2025

PRLD Investors Have Opportunity to Join Prelude - GlobeNewswire

Nov 26, 2025

Nov 25, 2025

This trade activity should not be overlooked: Prelude Therapeutics Inc (PRLD) - Setenews

Nov 25, 2025

Nov 21, 2025

Prelude Therapeutics Experiences Revision in Its Stock Evaluation Amid Mixed Financial Trends - Markets Mojo

Nov 21, 2025

Nov 20, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics IncorporatedPRLD - PR Newswire

Nov 20, 2025

Nov 19, 2025

Will Prelude Therapeutics Incorporated stock outperform Dow Jones indexJuly 2025 Sentiment & Smart Money Movement Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is Prelude Therapeutics Incorporated stock supported by innovation pipeline2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation ... - Bakersfield.com

Nov 19, 2025

Nov 19, 2025

Prelude Therapeutics Incorporated (PRLD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 19, 2025

Nov 19, 2025

What to do if you’re stuck in Prelude Therapeutics IncorporatedPortfolio Update Summary & Smart Investment Allocation Insights - newser.com

Nov 19, 2025

Nov 19, 2025

Prelude Advances Two Novel Cancer Programs as Cash Runway Extends Into 2027 - MyChesCo

Nov 19, 2025

Nov 19, 2025

Is Prelude Therapeutics Incorporated stock ready for a breakoutJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com

Nov 19, 2025

Nov 19, 2025

What sentiment indicators say about Prelude Therapeutics Incorporated stock2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com

Nov 19, 2025

Nov 18, 2025

Order flow analysis tools used on Prelude Therapeutics IncorporatedJuly 2025 Sector Moves & Daily Volume Surge Signals - newser.com

Nov 18, 2025

Nov 17, 2025

Can Prelude Therapeutics Incorporated stock hit analyst price targets2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com

Nov 17, 2025

Nov 17, 2025

Real time alert setup for Prelude Therapeutics Incorporated performanceProduct Launch & Safe Entry Trade Signal Reports - newser.com

Nov 17, 2025

Nov 17, 2025

Is Prelude Therapeutics Incorporated stock supported by strong fundamentalsJuly 2025 Market Mood & Weekly Breakout Stock Alerts - newser.com

Nov 17, 2025

Nov 17, 2025

Century Therapeutics Unveils iPSC Beta Islet Program as Cash Runway Extends Into 2027 - MyChesCo

Nov 17, 2025

Nov 17, 2025

Using flow based indicators on Prelude Therapeutics Incorporated2025 Market Sentiment & Fast Moving Trade Plans - newser.com

Nov 17, 2025

Nov 17, 2025

Taking on analysts’ expectations and winning: Prelude Therapeutics Inc (PRLD) - Setenews

Nov 17, 2025

Nov 17, 2025

Prelude Therapeutics’ Earnings Call Highlights Strategic Moves and Challenges - MSN

Nov 17, 2025

Nov 16, 2025

Published on: 2025-11-16 22:10:23 - newser.com

Nov 16, 2025

Nov 16, 2025

What institutional flow reveals about Prelude Therapeutics IncorporatedJuly 2025 Earnings & Safe Capital Growth Tips - newser.com

Nov 16, 2025

Nov 16, 2025

Is Prelude Therapeutics Incorporated stock a defensive play in 2025Weekly Risk Summary & Daily Oversold Bounce Ideas - newser.com

Nov 16, 2025

Nov 16, 2025

How to build a custom watchlist for Prelude Therapeutics IncorporatedJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com

Nov 16, 2025

Nov 16, 2025

Pattern recognition hints at Prelude Therapeutics Incorporated upsideSwing Trade & Advanced Technical Analysis Signals - newser.com

Nov 16, 2025

Nov 15, 2025

How moving averages guide Prelude Therapeutics Incorporated tradingBuy Signal & Weekly Breakout Watchlists - newser.com

Nov 15, 2025

Nov 15, 2025

Can Prelude Therapeutics Incorporated stock sustain free cash flow growthJuly 2025 Price Swings & Community Trade Idea Sharing Platform - newser.com

Nov 15, 2025

Nov 14, 2025

Volume spikes in Prelude Therapeutics Incorporated stock – what they meanMarket Performance Report & Daily Stock Momentum Reports - newser.com

Nov 14, 2025

Nov 14, 2025

Prelude Therapeutics Incorporated (NASDAQ:PRLD) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 14, 2025

Nov 14, 2025

Will Prelude Therapeutics Incorporated stock deliver shareholder valueTrade Exit Summary & AI Forecast for Swing Trade Picks - newser.com

Nov 14, 2025

Nov 14, 2025

Published on: 2025-11-14 02:04:28 - newser.com

Nov 14, 2025